This Amazing Little Device Could Be The Future Of Medical Marijuana

The Syqe Vaporizer

A company based in Tel Aviv, Israel has come up with a vaporizer that could revolutionize everything we know about medical cannabis. The device is called the Syqe Inhaler. It uses some clever new technology to deliver precise doses of medical cannabis.

How It Works

The Syqe Inhaler is a small, portable vaporizer that takes care of pretty much everything. And that starts with the bud itself.

Instead of having to mess with raw flower, patients who use the Syqe Inhaler rely on specially designed “preloaded cartridges.” Each cartridge comes packed with a specific amount of raw, whole-plant cannabis. These cartridges allow for perfectly precise doses every time you hit it.

Loading the cartridge into the vaporizer is pretty much the only work you have to do. You don’t even have to press any power buttons or anything. Just put the Syqe Inhaler to your lips and inhale. A built-in sensor detects your breath and immediately starts vaporizing the cannabis.

Research While You Medicate

The Syqe Inhaler doesn’t stop there. It also helps gather data about how you medicate. That data can be used in a couple of important ways.

First off, it can help you better understand what works and what doesn’t when it comes to your personal treatment. The device can sync up with your mobile devices. The app then lets you view all the information you’d ever need about your medication and how well it’s working. This can help you fine-tune the way you medicate.

Second, the device gathers data that can be used by researchers. One of the big challenges still facing the medical cannabis world is research. In fact, when the DEA chose not to reschedule cannabis this summer, it said that a key factor was that cannabis doesn’t have any proven medical benefits.

If doctors could get their hands on larger and more reliable data sets, it could help them conduct important research. And that research could help open the way for more legalization.

The data gathered by the Syqe Inhaler can provide important information to both patients and researchers. And along the way, it could help legitimize medical cannabis by giving researchers the data they need.

The Final Hit

So far, the response for the device has been positive. The company has raised more than $30 million for the new product. A large portion of that reportedly came from big tobacco company Philip Morris. Reuters said the corporation invested $20 million in the device. On top of that, Syqe Medical has already run the vaporizer through some successful clinical tests.